Author Page for Andrew Protheroe

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Final Analysis of LATITUDE, a Phase 3 Study of Abiraterone Acetate Plus Prednisone in Patients with Newly Diagnosed High-Risk Metastatic Castration-Sensitive Prostate Cancer

Number of pages: 178 Posted: 08 Jan 2019

Karim Fizazi, NamPhuong Tran, Luis Fein, Nobuaki Matsubara, Alfredo Rodriguez-Antolin, Boris Y. Alekseev, Mustafa Özgüroğlu, Dingwei Ye, Susan Feyerabend, Andrew Protheroe, Giri Sulur, Yesenia Luna, Susan Li, Suneel Mundle and Kim N. Chi

Université Paris XI Sud - Gustave Roussy Cancer Campus, Janssen Research & Development, LLC, Institute of Oncology of Rosario, National Cancer Center Hospital East, 612 de Octubre University Hospital, PA Hertsen Moscow Cancer Research Institute, Istanbul University, Fudan University - Shanghai Cancer Center (FUSCC), Studienpraxis Urologie, University of Oxford, Janssen Research & Development, LLC, Janssen Research & Development, LLC, Janssen Research & Development, LLC, Janssen Research & Development, LLC and BC Cancer Agency (BCCA)

Downloads 90 (742,061)

Citation 2

Andrew Protheroe

University of Oxford

1

90

2

Scholarly Papers (1)

Final Analysis of LATITUDE, a Phase 3 Study of Abiraterone Acetate Plus Prednisone in Patients with Newly Diagnosed High-Risk Metastatic Castration-Sensitive Prostate Cancer

Abstract: